Mydriatic

SAN FRANCISCO — The EyeArt artificial intelligence eye screening system showed high sensitivity and high specificity for diabetic retinopathy in a pivotal multicenter clinical trial, according to a speaker here.

A 35-year-old Caucasian man with a medical history of migraine headaches presented to the emergency room for acute onset of blurred vision and tunnel vision that began when he woke up in the morning. In addition to blurred vision, he complained of a mild headache with a pressure sensation behind his eyes. He denied eye pain, nausea and vomiting.